ResMed | RMD - Pre Tax Profit

Stock Price
230.70
Daily Change
4.65 2.06%
Monthly
-8.79%
Yearly
6.59%
Q2 Forecast
217.34

ResMed reported $482.38M in Pre-Tax Profit for its fiscal quarter ending in September of 2025.





Pre Tax Profit Change Date
Ansell USD 33.35M 74.15M Jun/2025
Artivion USD 11.4M 7.84M Dec/2025
AtriCure USD 2.36M 2.45M Dec/2025
Baxter International USD 121M 12M Sep/2025
Cochlear AUD 121.1M 155.6M Jun/2025
Cooper Companies USD 116.8M 137.4M Sep/2025
CSL USD 2.61B 1.21B Dec/2025
Dexcom USD 300M 58.9M Sep/2025
Edwards Lifesciences USD 348.4M 51.8M Sep/2025
Fisher Paykel Healthcare NZD 296.9M 90.5M Jun/2025
Globus Medical USD 143.99M 44.18M Sep/2025
Haemonetics USD 59.97M 8.69M Dec/2025
Hologic USD 229.7M 2.3M Dec/2025
Idexx Laboratories USD 306.98M 37.79M Dec/2025
Inogen USD -6.06M 467K Sep/2024
Insulet USD 140.2M 17.4M Dec/2025
Integra LifeSciences USD -6.82M 524.13M Sep/2025
Intuitive Surgical USD 855.2M 23.1M Sep/2025
Masimo USD 74.9M 19.5M Sep/2025
Medtronic USD 2.1B 224M Sep/2025
Philips EUR 275M 62M Sep/2025
Ramsay Health Care AUD 103.75M 54.35M Jun/2025
ResMed USD 482.38M 2.51M Sep/2025
Sigma Healthcare AUD 8.15M 7.4M Jul/2024
Sonic Healthcare AUD 402.01M 53.16M Jun/2025
Steris USD 324.4M 92.5M Sep/2025
Teleflex USD -438.58M 573.82M Sep/2025
Thermo Fisher Scientific USD 2.12B 295M Dec/2025